
-
Bird call contest boosts conservation awareness in Hong Kong's concrete jungle
-
Kneecap to play Paris concert in defiance of objections
-
Indonesian child's viral fame draws tourists to boat race
-
LAFC's Son, Whitecaps' Mueller score first MLS goals
-
Australian quick Morris out for 12 months with back injury
-
Son scores first MLS goal as LAFC draw 1-1 with Dallas
-
India's Modi dangles tax cuts as US tariffs loom
-
Indonesia turns down ear-splitting 'haram' street parties
-
North Korea test-fires two new air defence missiles: KCNA
-
Sinner, Sabalenka chasing rare repeats as US Open gets underway
-
Venezuela rallies militia volunteers in response to US 'threat'
-
Musk's megarocket faces crucial new test after failures
-
UK's mass facial-recognition roll-out alarms rights groups
-
Home hope Henderson, Aussie Lee share Canadian Women's Open lead
-
Fucsovics holds off van de Zandschulp for ATP Winston-Salem crown
-
Fleetwood, Cantlay share PGA Tour Championship lead
-
Argentina stun All Blacks with historic 29-23 upset win
-
France begin Women's Rugby World Cup with hard-fought win over Italy
-
Barca complete late comeback win as Atletico drop more points in Liga
-
Alcaraz targeting 'unbelievable' Sinner at US Open
-
Swiatek plays down favorite status ahead of US Open
-
De Bruyne strikes in Napoli's strong start as Modric's Milan sank by Cremonese
-
Springboks back in contention after win - Erasmus
-
Cirstea downs Li to claim WTA Cleveland crown
-
Nigeria says killed over 35 jihadists near Cameroon border
-
Sri Lanka ex-president rushed to intensive care after jailing
-
Russia claims more Ukraine land as hopes for summit fade
-
Atletico still without Liga win after Elche draw
-
Schell shock as six-try star leads Canada to 65-7 World Cup hammering of Fiji
-
Gyokeres scores twice but injuries to Saka, Odegaard sour Arsenal rout of Leeds
-
Leverkusen stumble in Ten Hag Bundesliga debut, Dortmund collapse late
-
Man City revamp rocked by Spurs, Arsenal thrash Leeds
-
Gyokeres scores twice as Arsenal rout Leeds
-
De Bruyne strikes in Napoli's strong start to Scudetto defence at Sassuolo
-
Seoul says fired warning shots after North Korean troops crossed border
-
McGhie the hat-trick heroine as Scotland overwhelm Wales in Women's Rugby World Cup
-
'It's in my DNA': Williams relishes US Open return at 45
-
Portugal suffers new wildfire death as Spain beats back blazes
-
Pollard steers Springboks to victory over Wallabies
-
Aubameyang stars as Marseille end chaotic week on five-goal high
-
US govt wants migrant targeted in crackdown deported to Uganda: lawyers
-
Man City revamp rocked by Spurs, Villa beaten at Brentford
-
Philipsen wins Vuelta a Espana opening stage
-
Crystal Palace's Eze returns to boyhood club Arsenal
-
Reyna trades Dortmund for Gladbach chasing 'new chapter'
-
Leverkusen stumble in Ten Hag Bundesliga debut
-
'Far too late': Palestinians despair after UN declares famine in Gaza
-
Diamond sparkles for Irish training icon Mullins in the Ebor
-
Tottenham's new-found desire to defend delights Frank
-
Man City troubles reappear as solid Spurs go top

Who should get paid for nature's sequenced genes?
Much of the vanilla that flavors our ice cream today is artificial, derived from the genetic signature of a plant that hundreds of years ago was known only to an Indigenous Mexican tribe.
The plant's sequenced genomic information, available on public databases, was used as the basis for a synthetic flavoring that today competes with vanilla grown in several countries, mainly by small-scale farmers.
Few, if any, benefits of the lucrative scientific advance have trickled down to the communities that gave us vanilla in the first place.
"Wild genetic resources and pharmaceuticals ... are a multi-multi-billion dollar businesses. They clearly are profitable... that's not in dispute," Charles Barber of the World Resources Institute think tank told AFP.
"A great deal of really valuable information has fed into the system from research and utilization of wild genetic resources. And there is no mechanism currently to compensate the people where this information is coming from" in the form of digitally sequenced data, he added.
Much of the information comes from poor countries.
Fair sharing of the gains derived from digitally-stored genetic sequencing data has been a headache for negotiators at the COP16 biodiversity summit into its second week in Cali, Colombia.
At the last conference, in Montreal in 2022, 196 country parties to the UN's Convention on Biological Diversity (CBD) agreed to create a benefit-sharing mechanism for the use of digital sequence information (DSI).
Two years later, they still need to resolve such basic questions as who pays, how much, into which fund, and to whom does the money go?
- 'Cheap and very fast' -
The issue is a complex one.
There is little debate that genetic data-sharing on mostly free-access platforms is crucial for human advancement through medicine and vaccine development, for example.
But how to quantify the value of the sequenced information itself? And should the first people to discover a plant's particular usefulness be compensated?
"Sequencing technology has become so advanced that you can go with a... handheld device a little bit bigger than a cell phone and you can literally sequence a genome in an hour or two and upload it as you sequence it," Pierre du Plessis, a DSI expert and former negotiator for African countries at the CBD told AFP.
These gene sequences are then uploaded to databases which artificial intelligence can mine for potential leads for product development.
DSI is worth an estimated hundreds of billions of dollars a year. And there is a lot of it out there.
"Once the sequence is put into a public database, generally, no benefit-sharing obligations apply," Nithin Ramakrishnan, a researcher with the Third World Network, an advocacy NGO for developing countries, told AFP in Cali.
"Like when the sandalwood sequence information is available in the database whether India wants to share its sandalwood... with a cosmetic company or not, doesn't matter.
- Mandatory -
A point of contention in Cali is a demand from developing countries that payment for DSI use be mandatory, perhaps through a one-percent levy on profits from drugs, cosmetics or other products.
They also want guarantees of non-monetary benefits such as access to vaccines produced from genetic information sequenced from viruses and other pathogens.
"We want real understanding, sector-specific understanding of what non-monetary benefits will be shared and we want the system to be obligatory -- the users should have some form of obligation to share benefits," said Ramakrishnan.
Another sticking point is access for Indigenous people and local communities to DSI funds.
Developing countries want the information on genetic databases to be traceable and "answerable to governments" of the countries where it comes from, said Ramakrishnan.
But rich nations and many researchers oppose such a model which they fear will be too onerous, potentially putting the brakes on scientific pursuits that could benefit all humankind.
With such divergent points of view, observers are doubtful the Cali COP will emerge with any firm decisions on the outstanding questions by closing time on Friday.
The World Wildlife Fund has said "many more rounds of negotiations appear necessary" on DSI.
Added Barber: "I think it's not going to all get solved here."
J.Oliveira--AMWN